Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Anaerococcus hydrogenalis

ABSTRACT: Whole genome sequencing of Peptoniphilus hydrogenalis, an opportunistic pathogen

PROVIDER: PRJDB1938 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	DRR016041_1.fastq.gz	Fastqsanger.gz
	DRR016041_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

Anaerococcus octavius

Project description:Whole genome sequencing of Anaerococcus octavius, an opportunistic pathogen

| PRJDB1784 | ENA

Peptoniphilus asaccharolyticus

Project description:Whole genome sequencing of Peptoniphilus asaccharolyticus, an opportunistic pathogen

| PRJDB2609 | ENA

Anaerococcus hydrogenalis

Project description:Anaerococcus hydrogenalis overview

| PRJNA37597 | ENA

Anaerococcus hydrogenalis strain:MJR7738A

Project description:HMP reference genome

| PRJNA272116 | ENA

Anaerococcus hydrogenalis DSM 7454

Project description:Reference genome for the Human Microbiome Project

| PRJNA30747 | ENA

Anaerococcus hydrogenalis TSDC16.1-1.1

Project description:Strain Anaerococcus hydrogenalis TSDC16.1-1.1 (species Anaerococcus vaginalis) was isolated from the fecal microbiota of a USA female at time point zero . The species name was assigned by genome clustering.

| PRJEB3624 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Anaerococcus hydrogenalis ACS-025-V-Sch4

Project description:Reference genome for Human Microbiome Project

| PRJNA52027 | ENA

Citrobacter murliniae

Project description:Whole genome sequencing of Citrobacter murliniae, an opportunistic pathogen

| PRJDB1996 | ENA

Streptococcus canis

Project description:Whole genome sequencing of Streptococcus canis, an opportunistic pathogen

| PRJDB2007 | ENA